Producing nature's gene-chips: The generation of peptides for display by MHC class I molecules

Annual Review of Immunology

Volumn 20, Issue , 2002, Pages 463-493

  Shastri, Nilabh ^a   Schwab, Susan ^a   Serwold, Thomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen presentation; Antigen processing; ER proteolysis; Proteasome

Indexed keywords

AMINOPEPTIDASE; CD8 ANTIGEN; GENE PRODUCT; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POLYPEPTIDE; PROTEASOME;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGENICITY; CYTOPLASM; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOGENETICS; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

AMINOPEPTIDASES; ANIMALS; ANTIGEN PRESENTATION; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MODELS, IMMUNOLOGICAL; MULTIENZYME COMPLEXES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE LIBRARY; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0036218697     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.20.100301.064819     Document Type: Review

References (135)

1. The nature of the MHC class I peptide loading complex
2. Genes regulating MHC class I processing of antigen
3. Tapasin: An ER chaperone that controls MHC class I assembly with peptide
4. Selective export of MHC class I molecules from the ER after their dissociation from TAP
5. + T cell responses to infectious agents, tumors, transplants, and vaccines
6. Antigen traffic pathways in dendritic cells
7. Dendritic cells resurrect antigens from dead cells
8. Dendritic cells: Specialized and regulated antigen processing machines
9. Generation of class I MHC-restricted T-T hybridomas
10. Measurement of ligand induced activation in single viable T-cells using the lacZ reporter gene
11. LacZ inducible peptide/MHC specific T-hybrids
12. Identification of classical minor histocompatibility antigen as cell-derived peptide
13. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y
14. HLA-A2.1-associated peptides from a mutant cell line: A second pathway of antigen presentation
15. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells
16. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition
17. An HLA-A2 restricted tyrosinase antigen on melanoma cells results from post-translational modification and suggests a distinct antigen processing pathway for membrane proteins
18. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo
19. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody
20. Identification of T-cell epitopes: Rapid isolation of class I-presented peptides from viable cells by mild acid elution
21. Proteasomes can either generate or destroy MHC class I epitopes: Evidence for nonproteasomal epitope generation in the cytosol
22. Reading within the lines: Naturally processed peptides displayed by MHC class I molecules
23. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules
24. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
25. + T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing
26. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product
27. Introduction of soluble protein into the class I pathway of antigen processing and presentation
28. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes
29. Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein
30. Identification of the rat maternally transmitted minor histocompatibility antigen
31. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: Transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol
32. The N-end rule: Functions, mysteries, uses
33. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation
34. The Listeria monocytogenes-secreted p60 protein is an N-end rule substrate in the cytosol of infected cells: Implications for major histocompatibility complex class antigen processing of bacterial proteins
35. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen
36. Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen
37. Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors
38. The major substrates for TAP in vivo are derived from newly synthesized proteins
39. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
40. Defective ribosomal products (DRiPs): A major source of antigenic peptides for MHC class I molecules?
41. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation
42. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences
43. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
44. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis
45. Coupled transcription and translation within nuclei of mammalian cells
46. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames
47. Major histocompatibility class I molecules can present cryptic translation products to T-cells
48. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism
49. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation
50. The three-dimensional structure of peptide-MHC complexes
51. b
52. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site
53. a
54. T cell receptor-MHC interactions up close
55. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes
56. The peptide-binding motif for the human transporter associated with antigen processing
57. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response
58. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry
59. Identification of a peptide recognized by five melanoma-specific human cytoxic T cell lines
60. + T cells can recognize unusual, rare, and unique processed peptide/MHC complexes
61. Minors held by majors. The H13 minor histocompatibility locus defined as a peptide/MHC class I complex
62. b molecule
63. Cellular peptide composition governed by major histocompatibility complex class I molecules
64. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
65. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96-GRP94
66. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends upon its neighboring residues in the protein
67. Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression
68. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes
69. Presentation without processing of endogenous precursors in the MHC class I presentation pathway
70. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies
71. Antigen presentation: Naturally processed peptides
72. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands
73. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER
74. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells
75. Structural and Serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes
76. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
77. Degradation of cell proteins and the generation of MHC class I-presented peptides
78. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: Involvement of nonproteasomal cytosolic proteases in antigen processing?
79. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors
80. The specificity of proteasomes: Impact on MHC class I processing and presentation of antigens
81. Antigen processing by the proteasome
82. The genetics of proteasomes and antigen processing
83. A proteolytic system that compensates for loss of proteasome function
84. A giant protease with potential to substitute for some functions of the proteasome
85. Altered peptidase and viral specific T cell response in LMP2 mutant mice
86. MHC class I expression in mice lacking the proteasome subunit LMP-7
87. Impaired immunoproteasome assembly and immune responses in PA28-/-mice
88. + T cells
89. Impaired assembly yet normal trafficking of MHC class I molecules in tapasin mutant mice
90. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice
91. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide
92. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides
93. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide
94. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
95. Transporter-independent processing of Hiv-1 envelope protein for recognition by CD8-positive T cells
96. + CTL
97. Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase
98. Two new proteases in the MHC class I processing pathway
99. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes
100. Trimming of antigenic peptides in an early secretory compartment
101. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing
102. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum
103. The Rat cim Effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER
104. Generation, translocation, and presentation of MHC class I-restricted peptides
105. How selective is the transporter associated with antigen processing?
106. Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses
107. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
108. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules
109. Association of class I major histocompatibility heavy and light chains induced by viral peptides
110. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells
111. Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells
112. An endoplasmic reticulum protein implicated in chaperoning peptides to major histocompatibility of class I is an aminopeptidase
113. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum
114. Cytotoxic T cell recognition of the SV40 tumor antigen: A note of caution
115. Genes coding for T-cell-defined tum transplantation antigens: Point mutations, antigenic peptides, and subgenic expression
116. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes
117. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product
118. b complex to T-cells
119. Identification of a unique antigen peptide pRL1 on BALB-c RL1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene
120. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma
121. b major histocompatibility complex class I molecule to alloreactive T cells
122. Recognition of out-of-frame major histocompatibility complex class I-restricted epitopes in vivo
123. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene
124. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen
125. Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression
126. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes
127. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
128. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus
129. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes
130. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames
131. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1
132. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia
133. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ
134. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes